Epstein-Barr virus-associated smooth muscle tumors in a composite tissue allograft and a pediatric liver transplant recipient

Transplant Infectious Disease

Volumn 15, Issue 5, 2013, Pages

  Conrad, A ^a   Brunet, A S ^b   Hervieu, V ^a   Chauvet, C ^a   Buron, F ^a   Collardeau Frachon, S ^b   Rivet, C ^b   Cassier, P ^c   Testelin, S ^d   Lachaux, A ^b,e   Morelon, E ^a,e   Thaunat, O ^a,e  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b HOSPICES CIVILS DE LYON   (France)

^c CENTRE LÉON BÉRARD   (France)

^d AMIENS UNIVERSITY HOSPITAL   (France)

^e UNIVERSITÉ LYON 1   (France)

Author keywords

Composite tissue allotransplantation; Epstein Barr virus; Face transplantation; Post transplant lymphoproliferative disorders; Post transplant smooth muscle tumors; PTLD

Indexed keywords

ALEMTUZUMAB; BASILIXIMAB; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DOXORUBICIN; FOSCARNET; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY; TRABECTEDIN; VALACICLOVIR; VALGANCICLOVIR; VINCRISTINE;

ACUTE GRAFT REJECTION; ADULT; ALLOGRAFT; ANTIVIRAL THERAPY; ARTICLE; B CELL LYMPHOMA; BILE DUCT ATRESIA; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CHILD; CLINICAL FEATURE; COMPOSITE GRAFT; CYTOMEGALOVIRUS INFECTION; EPSTEIN BARR VIRUS INFECTION; FOLLOW UP; GRAFT RECIPIENT; HERPES SIMPLEX; HERPES ZOSTER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; LIVER GRAFT; LIVER TUMOR; MALE; MULTIPLE CYCLE TREATMENT; MUSCLE TUMOR; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRESCHOOL CHILD; PRIORITY JOURNAL; TREATMENT DURATION; VIRUS LOAD; ADVERSE EFFECTS; EPSTEIN BARR VIRUS; EPSTEIN-BARR VIRUS INFECTIONS; FACIAL TRANSPLANTATION; FEMALE; GENETICS; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; ISOLATION AND PURIFICATION; LIVER TRANSPLANTATION; LYMPHOMA, B-CELL; POSTOPERATIVE COMPLICATIONS; SMOOTH MUSCLE TUMOR; VIROLOGY;

ADULT; ALLOGRAFTS; EPSTEIN-BARR VIRUS INFECTIONS; FACIAL TRANSPLANTATION; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSION; INFANT; LIVER TRANSPLANTATION; LYMPHOMA, B-CELL; MALE; POSTOPERATIVE COMPLICATIONS; SMOOTH MUSCLE TUMOR;

EID: 84884981503     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/tid.12126     Document Type: Article

References (23)

1. Cohen JI, Bollard CM, Khanna R, Pittaluga S. Current understanding of the role of Epstein-Barr virus in lymphomagenesis and therapeutic approaches to EBV-associated lymphomas. Leuk Lymphoma 2008; 49 (Suppl 1): 27-34.
2. Thorley-Lawson DA, Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 2004; 350 (13): 1328-1337.
3. de The G, Ablashi DV, Liabeuf A, Mourali N. Nasopharyngeal carcinoma (NPC). VI. Presence of an EBV nuclear antigen in fresh tumour biopsies. Preliminary results. Biomedicine 1973; 19 (8): 349-352.
4. Schulz TF. Cancer and viral infections in immunocompromised individuals. Int J Cancer 2009; 125.(8): 1755-1763.
5. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007; 370 (9581): 59-67.
6. Mierau GW, Greffe BS, Weeks DA. Primary leiomyosarcoma of brain in an adolescent with common variable immunodeficiency syndrome. Ultrastruct Pathol 1997; 21.(3): 301-305.
7. McClain KL, Leach CT, Jenson HB, et al. Association of Epstein-Barr virus with leiomyosarcomas in children with AIDS. N Engl J Med 1995; 332 (1): 12-18.
8. Lee ES, Locker J, Nalesnik M, et al. The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. N Engl J Med 1995; 332 (1): 19-25.
9. Pritzker KP, Huang SN, Marshall KG. Malignant tumours following immunosuppressive therapy. Can Med Assoc J 1970; 103 (13): 1362-1365.
10. Jonigk D, Laenger F, Maegel L, et al. Molecular and clinicopathological analysis of Epstein-Barr virus-associated posttransplant smooth muscle tumors. Am J Transplant 2012; 12 (7): 1908-1917.
11. Collins MH, Montone KT, Leahey AM, et al. Metachronous Epstein-Barr virus-related smooth muscle tumors in a child after heart transplantation: case report and review of the literature. J Pediatr Surg 2001; 36 (9): 1452-1455.
12. Deyrup AT, Lee VK, Hill CE, et al. Epstein-Barr virus-associated smooth muscle tumors are distinctive mesenchymal tumors reflecting multiple infection events: a clinicopathologic and molecular analysis of 29 tumors from 19 patients. Am J Surg Pathol 2006; 30 (1): 75-82.
13. Sprangers B, Smets S, Sagaert X, et al. Posttransplant Epstein-Barr virus-associated myogenic tumors: case report and review of the literature. Am J Transplant 2008; 8 (1): 253-258.
14. Brichard B, Smets F, Sokal E, et al. Unusual evolution of an Epstein-Barr virus-associated leiomyosarcoma occurring after liver transplantation. Pediatr Transplant 2001; 5 (5): 365-369.
15. Toh HC, Teo M, Ong KW, et al. Use of sirolimus for Epstein-Barr virus-positive smooth-muscle tumour. Lancet Oncol 2006; 7 (11): 955-957.
16. Al Hussain T, Haleem A, Alsaad KO. Synchronous hepatic, mesenteric and pulmonary Epstein-Barr virus-associated smooth muscle tumors in a renal transplant recipient. Clin Transplant 2010; 24 (5): 579-584.
17. Purgina B, Rao UN, Miettinen M, Pantanowitz L. AIDS-related EBV-associated smooth muscle tumors: a review of 64 published cases. Patholog Res Int 2011; 2011: 561548.
18. Ong KW, Teo M, Lee V, et al. Expression of EBV latent antigens, mammalian target of rapamycin, and tumor suppression genes in EBV-positive smooth muscle tumors: clinical and therapeutic implications. Clin Cancer Res 2009; 15 (17): 5350-5358.
19. Rougemont AL, Alfieri C, Fabre M, et al. Atypical Epstein-Barr virus (EBV) latent protein expression in EBV-associated smooth muscle tumours occurring in paediatric transplant recipients. Histopathology 2008; 53 (3): 363-367.
20. Hernando E, Charytonowicz E, Dudas ME, et al. The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas. Nat Med 2007; 13 (6): 748-753.
21. Shen Q, Feng W, Long MS, et al. Multicentric hepatic EBV-associated smooth muscle tumors in an AIDS patient: a case report, investigation of mTOR activation and review of the literature. Int J Clin Exp Pathol 2011; 4 (4): 421-429.
22. Bonatti H, Hoefer D, Rogatsch H, Margreiter R, Larcher C, Antretter H. Successful management of recurrent Epstein-Barr virus-associated multilocular leiomyosarcoma after cardiac transplantation. Transplant Proc 2005; 37 (4): 1839-1844.
23. Belingheri M, Comoli P, Locatelli F, et al. Successful medical treatment of EBV smooth muscle tumor in a renal transplant recipient. Pediatr Transplant 2010; 14 (8): E101-E104.